ACC Joins USMCA Coalition with Commitment to Promote Manufacturing Growth

American Chemistry Council, Inc | February 26, 2019

The American Chemistry Council (ACC) today reaffirmed its support for U.S. ratification of the United-States-Mexico-Canada Agreement (USMCA) by joining the USMCA Coalition, an alliance of more than 200 companies and associations which is urging congressional approval of the agreement. “U.S. chemicals manufacturers are pleased to join with our coalition partners to encourage passage of the USMCA in the Congress this year,” said Cal Dooley, ACC president and CEO. “The USMCA would bring significant added value to our industry, to the economy, and to continued efforts to protect human health and the environment throughout the region. It’s time to put this agreement to work for all Americans.” American chemicals manufacturers welcomed the signing of the USMCA last November and have pointed to the positive impacts that the USMCA would have on the industry. For example, ACC has said that it strongly supports the USMCA’s Sectoral Annex for Chemical Substances, which embraces the principles the North American chemical industry jointly recommended to promote regulatory compatibility through enhanced cooperation.

Spotlight

With target-oriented drug discovery and an increasing focus on specialized medicines, the manufacturing of final drug products is becoming more and more complex. The processing and formulation of active pharmaceutical ingredients (APIs) designed with a specific target and functionality in mind may present challenges during the development and manufacture of the final formulation. Aspects such as bioavailability of the API in the body, API stability, and low dosage formulations are frequent hurdles to be overcome when bringing a drug to the market.

Spotlight

With target-oriented drug discovery and an increasing focus on specialized medicines, the manufacturing of final drug products is becoming more and more complex. The processing and formulation of active pharmaceutical ingredients (APIs) designed with a specific target and functionality in mind may present challenges during the development and manufacture of the final formulation. Aspects such as bioavailability of the API in the body, API stability, and low dosage formulations are frequent hurdles to be overcome when bringing a drug to the market.

Related News

CHEMICAL TECHNOLOGY

NAPCO Pipe & Fittings Announces Completion of Acquisition of LASCO Fittings

NAPCO | August 24, 2021

North American Pipe Corporation (NAPCO), a subsidiary of Westlake Chemical Corporation, today announced that it acquired LASCO Fittings LLC, a Brownsville, Tennessee-based, leading designer, engineer and manufacturer of injected-molded PVC fittings, from Aalberts, NV. “We are pleased to complete this important strategic acquisition and to welcome LASCO Fittings and its talented team into the Westlake family of companies,” said Andre Battistin, vice president, NAPCO Pipe & Fittings. “By adding LASCO Fittings to our product mix, NAPCO will expand into additional markets, particularly as LASCO specializes in half-inch to four-inch fittings and serves the plumbing, pool and spa, industrial, irrigation and retail markets in the United States. LASCO’s product mix is very complementary to our existing range of pipe and fittings products primarily with diameters of four or more inches and will bring additional fittings products to NAPCO’s offerings.” LASCO Fittings will continue to operate a 48-acre, 500,000 square foot manufacturing and distribution facility in Brownsville, Tennessee, northeast of Memphis. It also has eight regional distribution facilities strategically located throughout the United States. The company employs about 560 employees. About NAPCO Pipe & Fittings NAPCO, a Westlake company, is a leading North American polyvinyl chloride (PVC) pipe manufacturer. Founded in 1992, NAPCO supplies a broad range of gasketed, solvent welded, and restrained joint pipes for a diverse range of markets, including municipal water and sewer, residential plumbing, water well, and agricultural and turf irrigation. The company has a large and seasoned R&D team driving product enhancements that deliver innovative solutions that meet customers’ most challenging needs. About Westlake Westlake is a global manufacturer and supplier of materials and innovative products that enhance life every day. Headquartered in Houston, we provide the building blocks for vital solutions from building products and infrastructure materials, to packaging and healthcare products, to automotive and consumer goods.

Read More

CHEMICAL TECHNOLOGY

Petrochemical Company Braskem Commits to Ending Plastic Waste

Braskem | November 13, 2020

Braskem, the largest polyolefins producer in the Americas and leading producer of biopolymers in the world, today announces its latest sustainability ambitions to significantly expand its efforts to eliminate plastic waste in the environment by 2030 and to achieve carbon neutrality by 2050. In 2009, Braskem launched the company's long-term sustainability goals for 2020, which emphasized Braskem's commitment to providing solutions that address climate change. Braskem has invested in the development of I'm green™ products sourced from renewable sources and recycled content, while in the same period reducing the intensity of carbon emissions from its operations by 20 percent. In 2018, Braskem further committed to 100% of plastic packaging being reused, recycled, or recovered by 2040. As part of its evolving sustainable development strategy, Braskem today announces additional commitments to mitigate climate change, eliminate plastic waste and provide solutions for recycled products in its markets.

Read More

BioLargo says BLEST subsidiary awarded contract to assist in the reconfiguration of Regenerative Thermal Oxidizer systems at a large chemicals plant

Jon Hopkins | October 22, 2020

BioLargo, Inc. has announced that its subsidiary BioLargo Engineering, Science & Technologies (BLEST) has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer (RTO) systems used at a large chemical manufacturing plant on the East Coast of the US. The plant, owned by a global chemical company, produces phenolic resins, antioxidants and related synthetic organic products. The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue, BioLargo said in a statement.

Read More